Retatrutide - 20MG
Free Shipping Over $300
7 Day Moneyback
Guaranteed 99%+ Purity
What is Retatrutide?
Retatrutide is a next-generation peptide that acts on GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This triple-action mechanism enhances insulin sensitivity, controls appetite, and accelerates fat metabolism. As one of the most advanced peptides for weight loss, Retatrutide is designed to support overall metabolic health while promoting effective weight management.
How Does Retatrutide Work?
Retatrutide’s unique triple-receptor mechanism targets the following: GLP-1 Receptor: Regulates blood sugar and enhances insulin sensitivity. GIP Receptor: Controls appetite and promotes satiety, reducing cravings. Glucagon Receptor: Boosts fat burning and accelerates metabolic rate. This combined action makes Retatrutide highly effective for weight loss, blood sugar control, and overall metabolic health.
Pharmacokinetics (PK) Summary
Peak Concentration: Peak plasma concentrations are reached roughly 24 to 72 hours after subcutaneous injection.
Metabolism: Like other therapeutic peptides, it is cleared via proteolytic degradation of the peptide backbone and beta-oxidation of the fatty acid side chain.
Half-Life: ~144 hours (6 days), supporting a steady-state concentration with weekly dosing.
Research Status and Safety
Retatrutide is currently in Phase 3 clinical trials (the TRIUMPH program). While its safety profile is largely consistent with other incretin mimetics (nausea, diarrhea), the glucagon component introduces a unique observation: a dose-dependent, transient increase in resting heart rate, which typically peaks around week 24 before declining.
